1. Double-mutant myeloproliferative neoplasms

   • Stephen E. Langabeer

   Letter to the Editor 29 August 2018 Article: 137

2. Dose-dense temozolomide for recurrent high-grade gliomas: a single-center retrospective study

   • Catherine R. Garcia
   • Stacey A. Slone
   • John L. Villano

   Original Paper 28 August 2018 Article: 136

   

3. Primary leiomyosarcoma of the skin: a comprehensive review on diagnosis and treatment

   • Martina Zacher
   • Markus V. Heppt
   • Carola Berking

   Review Article 23 August 2018 Article: 135

   

4. Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy

   • Guillaume Klausner
   • Eivind Blais
   • Idriss Troussier

   Review Article 20 August 2018 Article: 134

   

5. Significance of introduction of alternative dosing schedule for sunitinib during first-line treatment of patients with metastatic renal cell carcinoma

   • Hideaki Miyake
   • Yuto Matsushita
   • Atsushi Otsukav

   Original Paper 20 August 2018 Article: 133

   

6. Patient performance status and cancer immunotherapy efficacy: a meta-analysis

   • Melissa Bersanelli
   • Matteo Brighenti
   • Fausto Petrelli

   Review Article 20 August 2018 Article: 132

   

7. Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma

   • Alexandra Pender
   • Elizabeth J. Davis
   • Robin L. Jones

   Original Paper Open access 20 August 2018 Article: 131

   

8. Expression of Concern: Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer

   • Zhifeng Lin
   • Liwen Xiong
   • Qiang Lin

   Expression of Concern 18 August 2018 Article: 130

9. Expression of concern: Short hairpin RNA (shRNA) of type 2 interleukin-1 receptor (IL1R2) inhibits the proliferation of human osteosarcoma U-2 OS cells

   • Xiwei Liu
   • Li Min
   • Chongqi Tu

   Expression of Concern 17 August 2018 Article: 129

10. Pre-therapy CT scan showing peritoneal thickening from metastatic renal pelvis carcinoma patients

    • Tzu-Yao Liao
    • Chuang-Chi Liaw
    • Yu-Hsiang Juan

    Original Paper Open access 16 August 2018 Article: 128

    

11. Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues

    • Anchalee Tantiwetrueangdet
    • Ravat Panvichian
    • Surasak Leelaudomlipi

    Original Paper Open access 16 August 2018 Article: 127

    

12. Sorafenib in patients with progressed and refractory bone tumors

    • Anna Raciborska
    • Katarzyna Bilska

    Short Communication Open access 16 August 2018 Article: 126

    

13. Association of baseline patient characteristics with adjuvant chemotherapy toxicities in stage III colorectal cancer patients

    • Akie Watanabe
    • Chang Cheng Yang
    • Winson Y. Cheung

    Original Paper 16 August 2018 Article: 125